Allscripts Healthcare buy Royal Bank of Canada
Start price
19.01.24
/
50%
€8.20
Target price
19.01.25
€10.11
Performance (%)
-24.39%
Price
30.04.24
€7.30
Summary
This prediction is currently active. The prediction for Allscripts Healthcare disappoints with a performance of -24.39%. This prediction currently runs until 19.01.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Allscripts Healthcare | 5.797% | 5.797% |
iShares Core DAX® | 0.000% | -2.064% |
iShares Nasdaq 100 | 0.626% | -2.884% |
iShares Nikkei 225® | 1.568% | -5.892% |
iShares S&P 500 | 0.334% | -2.281% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Allscripts Healthcare diskutieren
Veradigm Inc. (NASDAQ: MDRX) had its price target lowered by analysts at Royal Bank of Canada from $22.00 to $11.00. They now have an "outperform" rating on the stock.
Ratings data for MDRX provided by MarketBeat